98%
921
2 minutes
20
Introduction: Peroral endoscopic myotomy (POEM) has been established as a safe and effective intervention for Type I and II achalasia. Studies have shown that short POEM is non-inferior to long POEM, with some evidence of decreased incidence of gastroesophageal reflux disease (GERD). This meta-analysis aims to systematically review and analyze randomized controlled trials (RCTs) data comparing clinical and safety outcomes for long and short POEM procedures while further investigating differences in GERD and other long-term clinical outcomes.
Methods: We conducted a comprehensive search in PubMed, Embase, Cochrane, and Web of Science from inception until October 2024 for RCTs comparing long and short POEM procedures for the treatment of achalasia. Our pooled data was analyzed for clinical and objective procedural success, procedural adverse events, GERD outcomes, procedure time, and hospitalization time. A random effects model was used, and the data was presented using pooled odds ratios (OR) and mean differences (MD) with 95% confidence intervals (CI).
Results: Five RCTs were included with 518 achalasia patients (253 in short group and 265 in long group). Baseline characteristics of enrolled patients were similar across studies. Short and long POEM had similar clinical success (OR 1.18, 95% CI: 0.45-3.06, p = 0.73, I 0%), procedural adverse events (OR 0.72, 95% CI: 0.33-1.54, p = 0.39, I 0%), hospitalization time (0.14 days, 95% CI: - 0.13 to 0.40, p = 0.31, I 0%). Short POEM had shorter procedure time (MD - 16.68 min, 95% CI: - 22.77 to - 10.59, p < 0.00001, I 75%). The groups had similar symptomatic GERD (OR 0.86, 95% CI: 0.52-1.44, p = 0.57, I 0%), however short POEM had significantly lower acid exposure time (OR 0.62, 95% CI: 0.38 to 0.99, p = 0.04, I 0%) and erosive esophagitis after sensitivity analysis (OR 0.52, 95% CI: 0.27 to 1.01, p = 0.05, I 0%).
Conclusion: Our study demonstrates that short POEM is clinically non-inferior to long POEM but has advantages in shorter procedure time and lower odds of objective evidence of gastroesophageal reflux disease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00464-025-12155-9 | DOI Listing |
Surg Endosc
September 2025
Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Introduction: Peroral endoscopic myotomy (POEM) has been established as a safe and effective intervention for Type I and II achalasia. Studies have shown that short POEM is non-inferior to long POEM, with some evidence of decreased incidence of gastroesophageal reflux disease (GERD). This meta-analysis aims to systematically review and analyze randomized controlled trials (RCTs) data comparing clinical and safety outcomes for long and short POEM procedures while further investigating differences in GERD and other long-term clinical outcomes.
View Article and Find Full Text PDFJ Clin Gastroenterol
September 2025
Department of Internal Medicine, Virtua Health Inc, Voorhees, NJ.
Background: Peroral endoscopic myotomy (POEM) is a standard achalasia treatment, matching surgery in efficacy. However, myotomy length varies. Shorter myotomies are gaining attention for potential benefits.
View Article and Find Full Text PDFNeurogastroenterol Motil
August 2025
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Background: Achalasia is associated with an increased risk of esophageal cancer; though reported incidence rates vary widely (0.4% to 9.2%) due to differences in demographics, follow-up duration, and diagnostic methods.
View Article and Find Full Text PDFSurg Endosc
August 2025
Division of Gastroenterology, Department of Internal Medicine, Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA.
Background: Treatment of Zenker's diverticulum (ZD) has been revolutionized with the introduction of endoscopic techniques. Z-POEM has been shown to have excellent safety and efficacy. We report our experience with the Z-POEM for the treatment of ZD.
View Article and Find Full Text PDFMethodist Debakey Cardiovasc J
August 2025
Emeritus Executive Director of Academic Affairs, Cleveland Clinic and Emeritus Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio US.
This edition of Poet's Pen focuses on a rare but catastrophic complication associated with methamphetamine, the use of which is progressively rising in certain parts of the country. The featured poem, "The Pulse of a Silent Killer," shows the utility of poetry to sound the alarm amidst an emergency, alerting the medical community that all may not be as it seems. According to its author, the piece "reflects the rising crisis of methamphetamine-induced cardiomyopathy among young adults in Texas.
View Article and Find Full Text PDF